PEMGARDA™ (pemivibart) net product revenue of $11.3 million reported for Q1 2025, influenced by planned transition (Jan/Feb) from a contracted to an internalized sales forcePEMGARDA revenue re-acceleration observed in Q2 2025 to dateInvivyd continues to target near-term profitability (1H 2025) with existing cash and cash equivalents, anticipated growth of net product revenue, and continued reduction of operating expensesSince Emergency Use Authorization (EUA) of PEMGARDA in March 2024, no documented cases o ...

American Shared Hospital Services Reports First Quarter 2025 Financial Results Reports 17% Year over Year First Quarter Revenue GrowthConference Call Scheduled for 12:00 PM ET TodaySAN FRANCISCO, CA, May 15, 2025 – PRISM MediaWire – American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing and direct patient care services segments, today announced financial re ...

GERMANY - 2025/04/06: In this photo illustration, Advanced Micro Devices Inc. logo is seen displayed ... More on a monitor. (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesAdvanced Micro Devices stock (NASDAQ:AMD) increased by more than 4% during Tuesday's trading session and has risen by nearly 20% over the last month. What factors are contributing to the stock's upward trend?New $10 Billion Agreement in Saudi ArabiaTuesday saw AMD unve ...

Core Viewpoint - FONAR Corporation reported its financial results for the third quarter and nine-month period of fiscal 2025, highlighting growth in revenues but a decline in income from operations and net income for the nine-month period compared to the previous year [2][3][7]. Financial Performance - Total Revenues-Net for the quarter ended March 31, 2025, increased by 6% to $27.2 million compared to $25.7 million for the same quarter in 2024 [3][10]. - Total Revenues-Net for the nine-month period ended March 31, 2025, was $77.1 million, slightly up from $76.9 million for the same period in 2024 [3][50]. - Income From Operations for the quarter decreased by 2% to $3.66 million compared to $3.75 million for the same quarter in 2024 [6][10]. - Income From Operations for the nine-month period decreased by 30% to $10.7 million compared to $15.2 million for the same period in 2024 [6][50]. - Net Income for the quarter increased by 24% to $3.1 million compared to $2.5 million for the same quarter in 2024 [7][10]. - Net Income for the nine-month period decreased by 25% to $9.3 million compared to $12.5 million for the same period in 2024 [7][11]. Cost Analysis - Selling, general & administrative costs (SG&A) increased by 5% to $8.0 million for the quarter compared to $7.6 million in the same quarter of 2024 [4][10]. - SG&A costs increased by 11% to $20.1 million for the nine-month period compared to $18.0 million for the same period in 2024 [4][50]. - Total Costs and Expenses for the quarter were $23.5 million, up from $22.0 million in the same quarter of 2024 [5][10]. - Total Costs and Expenses for the nine-month period were $66.4 million compared to $61.7 million for the same period in 2024 [5][50]. Balance Sheet Highlights - Total Cash, Cash Equivalents, and Short-Term Investments decreased by 4% to $54.4 million as of March 31, 2025, compared to $56.5 million at June 30, 2024 [10][12]. - Total Current Assets increased to $141.1 million as of March 31, 2025, compared to $140.3 million at June 30, 2024 [12]. - Total Assets increased to $214.9 million as of March 31, 2025, compared to $214.2 million at June 30, 2024 [12][13]. - Total Current Liabilities decreased to $14.0 million as of March 31, 2025, compared to $17.9 million at June 30, 2024 [12][13]. Operational Achievements - The Health Management Company of America (HMCA) set a new record by completing 54,612 MRI scans in the third quarter of Fiscal 2025, which was 2.8% higher than the previous quarter and 3.4% higher than the same quarter in Fiscal 2024 [16]. - HMCA managed 44 MRI scanners, with plans to add more facilities to expand its network in New York and Florida [16][17]. Shareholder Actions - As of March 31, 2025, FONAR repurchased 373,942 shares at a cost of $6.07 million as part of its stock repurchase plan announced in September 2022 [17].

IRVINE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- SBCMedicalGroupHoldings (Nasdaq:SBC, "the Company") today announces that its Board of Directors has approved the following share repurchase program and will commence repurchasing its own shares as early as May 20, 2025. Share Repurchase Program The Company believes its current share price undervalues its business performance, the growth potential of the aesthetic‑medical market, and its position as an industry leader. Based on this view, it has decided to pur ...

Exploration Program for the Flagship Pine Ridge Uranium Project In Wyoming's Prolific Powder River Basin Priority Targets Identified, ~38,000m Drill Program Anticipated to Start in July 2025 May 15, 2025 7:00 AM EDT | Source: Snow Lake Resources Ltd Winnipeg, Manitoba--(Newsfile Corp. - May 15, 2025) - Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) ("Snow Lake"), a uranium exploration and development company, announces that an exploration program for the Pine Ridge Uranium Project ("Pine Ri ...

CALGARY, AB, May 15, 2025 /PRNewswire/ - Enbridge Inc. (Enbridge or the Company) (TSX: ENB) (NYSE: ENB) today announced an agreement whereby the Stonlasec8 Indigenous Alliance Limited Partnership (the "First Nations Partnership"), which currently represents 36 First Nations in B.C., will make an investment of approximately CAD$715 million in Enbridge's Westcoast natural gas pipeline system, resulting in the First Nations Partnership owning a 12.5% interest in that system, subject to certain closing conditio ...

– SLE and LN registrational discussions with FDA anticipated in 3Q25; systemic sclerosis registrational discussions with FDA anticipated in 4Q25 – – New clinical data on rese-cel in myositis, SLE / LN and systemic sclerosis to be presented in three oral sessions at the EULAR 2025 Congress in June – – Two subtype specific cohorts with ~15 patients each added to the ongoing RESET-Myositis™ trial – As of March 31, 2025, the Company had cash and cash equivalents of $131.8 million, per our Form 10-Q being filed ...

TEL AVIV, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- REE Automotive Ltd. (Nasdaq: REE) ("REE" or the "Company"), an automotive technology company that develops and builds software-defined vehicle technology and a provider of full by-wire electric trucks and platforms, today announced its fourth quarter and fiscal year 2024 financial results. "2024 was a breakthrough year for REE. We successfully accelerated our vision of software defined vehicle (SDV) technology from concept to commercial reality in 2024. We ...

"Over the past year, we've seen firsthand how a thoughtfully designed physical store can deepen engagement, drive growth, and introduce the Wayfair brand to entirely new audiences," said Liza Lefkowski, vice president of merchandising and stores at Wayfair. "The upcoming Yonkers store builds on that momentum—bringing our immersive retail experience to the New York metro area and delivering the same inspiration, convenience, and flexibility our customers have come to expect." Wilmette Store Sets the Standard ...